Entera Bio Ltd reports results for the quarter ended in December - Earnings Summary

Entera Bio

08/03/2022 19:51

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted
loss
of 21 cents​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 23 cents per share.
    * Revenue fell 25.3% to $165.00 thousand from a year ago; 
analysts expected $127.00 thousand. 
    * Entera Bio Ltd's reported EPS for the quarter was a loss
of 21
cents​.
    * The mean earnings estimate of analysts had fallen by
about 72.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Entera Bio Ltd shares had fallen by 20.4% this quarter.
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 8 at 07:51 p.m.  ​All
figures in US dollars unless otherwise stated